New COVID-19 Variant NB.1.8.1 Raises Alarm in California as FDA Adjusts Vaccine Policy Amidst Concerns
New COVID-19 variant NB.1.8.1 is causing concern in California, where it was first detected by Stanford scientists. The FDA, under Robert F. Kennedy Jr., has controversially limited vaccine eligibility, prioritizing high-risk individuals.












